GlassScriptPhysician profile
Michelle M Bosse
NPI 1437368842
$230.22
in general payments reported to CMS, 2019-2025
10 companies · $94.89 in 2025
The $94.89 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.16 · 2024: $120 · 2025: $94.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $59.81 | 2024-2025 | Qelbree |
| Noven Therapeutics, LLC | $30.64 | 2024-2025 | Xelstrym |
| Abbvie INC. | $22.17 | 2024 | |
| Corium, LLC | $21.75 | 2025 | Azstarys |
| Pfizer INC. | $19.72 | 2025 | |
| Seqirus USA INC | $17.25 | 2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $15.29 | 2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Alk-Abello, INC | $15.16 | 2023 | Ragwitek, Odactra, Grastek |
| Glaxosmithkline, LLC. | $14.33 | 2024 | Bexsero |
| Vertical Pharmaceuticals, LLC | $14.10 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Bosse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.